Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis
Name:
s41598-019-43849-5.pdf
Size:
4.738Mb
Format:
PDF
Description:
Final Published Version
Author
Łaniewski, PawełCui, Haiyan
Roe, Denise J
Barnes, Dominique
Goulder, Alison
Monk, Bradley J
Greenspan, David L
Chase, Dana M
Herbst-Kralovetz, Melissa M
Affiliation
Univ Arizona, Coll Med Phoenix, Dept Basic Med SciUniv Arizona, UA Canc Ctr
Univ Arizona, Coll Med Phoenix, Dept Obstet & Gynecol
Issue Date
2019-05-14
Metadata
Show full item recordPublisher
NATURE PUBLISHING GROUPCitation
Łaniewski, P., Cui, H., Roe, D. J., Barnes, D., Goulder, A., Monk, B. J., ... & Herbst-Kralovetz, M. M. (2019). Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Scientific reports, 9(1), 7333.Journal
SCIENTIFIC REPORTSRights
© The Author(s) 2019. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Persistent human papillomavirus (HPV) infection is the vital factor driving cervical carcinogenesis; however, other features of the local cervicovaginal microenvironment (CVM) may play a critical role in development of precancerous cervical dysplasia and progression to invasive cervical carcinoma (ICC). Here we investigated relationships between locally secreted cancer biomarkers and features of the local CVM to better understand the complex interplay between host, virus and vaginal microbiota (VMB). We enrolled women with ICC, high- and low-grade squamous intraepithelial lesions, as well as, HPV-positive and healthy HPV-negative controls. A broad range of cancer biomarkers was present in the local CVM and specifically elevated in ICC patients. The majority of cancer biomarkers were positively correlated to other biomarkers and linked to genital inflammation. Several cancer biomarkers were also negatively correlated to Lactobacillus abundance and positively correlated with abnormal vaginal pH. Finally, a hierarchical clustering analysis of cancer biomarkers and immune mediators revealed three patient clusters, which varied in levels of cancer biomarkers, genital inflammation, vaginal pH and VMB composition. Specific cancer biomarkers discriminated patients with features of the CVM, such as high genital inflammation, elevated vaginal pH and dysbiotic non-Lactobacillus-dominant VMB, that have been associated with HPV persistence, dysplasia and progression to ICC.Note
Open access journalISSN
2045-2322PubMed ID
31089160Version
Final published versionSponsors
Flinn Foundation [1974]; National Institutes of Health NIAID [1R15AI113457-01A1]; National Institutes of Health NCI [P30 CA023074]ae974a485f413a2113503eed53cd6c53
10.1038/s41598-019-43849-5
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s) 2019. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.
- Authors: Łaniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM
- Issue date: 2018 May 15
- Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
- Authors: Ilhan ZE, Łaniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM
- Issue date: 2019 Jun
- Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.
- Authors: Kaelin EA, Skidmore PT, Łaniewski P, Holland LA, Chase DM, Herbst-Kralovetz MM, Lim ES
- Issue date: 2022 Apr 26
- Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
- Authors: Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD, Costa Rica HPV Vaccine Trial (CVT) Group
- Issue date: 2020 Mar
- The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
- Authors: Gonçalves-Nobre JG, Matos A, Carreira M, Santos AC, Veiga LC, Ginete C, Brito M, Pires M, Pereira H, Cardoso C, Bicho M, Bicho MC
- Issue date: 2023

